Literature DB >> 1704426

Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.

E Sofic1, W Paulus, K Jellinger, P Riederer, M B Youdim.   

Abstract

Histochemical and biochemical determinations of total iron, iron (II), and iron (III) contents in brain regions from Parkinson's and Alzheimer's diseases have demonstrated a selective increase of total iron content in parkinsonian substantia nigra zona compacta but not in the zona reticulata. The increase of iron content is mainly in iron (III). The ratio of iron (II):iron (III) in zona compacta changes from almost 2:1 to 1:2. This change is thought to be relevant and may contribute to the selective elevation of basal lipid peroxidation in substantia nigra reported previously. Iron may be available in a free state and thus can participate in autooxidation of dopamine with the resultant generation of H2O2 and oxygen free radicals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704426     DOI: 10.1111/j.1471-4159.1991.tb02017.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  111 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron.

Authors:  Moussa B.H. Youdim; Edna Grünblatt; Yona Levites; Gila Maor; Silvia Mandel
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 3.  Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease.

Authors:  Julie K Andersen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Increased iron content in the putamen of patients with striatonigral degeneration.

Authors:  S Kato; S Meshitsuka; E Ohama; J Tanaka; J F Llena; A Hirano
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

Authors:  Jun Peng; May Lin Oo; Julie K Andersen
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

6.  Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders.

Authors:  Ling Lu; Long-Lian Zhang; G Jane Li; Wenrui Guo; Wannian Liang; Wei Zheng
Journal:  Neurotoxicology       Date:  2005-03       Impact factor: 4.294

Review 7.  Manganese toxicity upon overexposure.

Authors:  Janelle Crossgrove; Wei Zheng
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

Review 8.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

9.  Cell-cycle arrest and inhibition of G1 cyclin translation by iron in AFT1-1(up) yeast.

Authors:  C C Philpott; J Rashford; Y Yamaguchi-Iwai; T A Rouault; A Dancis; R D Klausner
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 10.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.